Replies to post #86752 on Biotech Values

[mouton29]

<<Why would the FDA trust MNTA and not TEVA regarding full characterization. The only reason I could think of would be MNTA's technology[>>

I just don't see what "trust" has to do with it. I assume the evidence in their submission -- or MNTA's technology as you put it -- would be the reason.